Harry Palmin

Opexa Therapeutics

Chief Operating Officer and Chief Financial Officer

Overview

Harry Palmin made an average of $561.3K in compensation at Opexa Therapeutics between 2017 and 2018.

Annual data

2018

In 2018, Harry Palmin earned a total compensation of $429.3K as Chief Operating Officer and Chief Financial Officer at Opexa Therapeutics.

Ranking7,451 out of 8,301
Percentile10.2%

Harry Palmin's 2018 compensation ranked 7,451st out of 8,301 executive pay records tracked by us this year.

Palmin earned more than 10.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking498 out of 542
Percentile8.1%

In the industry group of Drugs, Palmin's pay ranked 498th out of 542 executive pay records tracked by us in 2018.

Palmin earned more than 8.1% of executives in this group.

Bonus$89,250
Salary$340,000
Total$429,250

Palmin received $340K in salary, which accounts for 79.21% of total compensation.

Palmin also received $89.3K in bonus.

2017

In 2017, Harry Palmin earned a total compensation of $693.3K as Chief Financial Officer at Opexa Therapeutics.

Ranking9,655 out of 13,165
Percentile26.7%

Harry Palmin's 2017 compensation ranked 9,655th out of 13,165 executive pay records tracked by us this year.

Palmin earned more than 26.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,005 out of 1,395
Percentile28.0%

In the industry group of Drugs, Palmin's pay ranked 1,005th out of 1,395 executive pay records tracked by us in 2017.

Palmin earned more than 28.0% of executives in this group.

Option Awards$594,151
Salary$99,167
Total$693,318

Palmin received $594.2K in option awards, which accounts for 85.70% of total compensation.

Palmin also received $99.2K in salary.